10th Anniversary Spotlight
YU10 Programmheft
Download des Programmheftes
Follow a manual added link
10th Anniversary Spotlight
We invite you to join us on our journey through YUMABS milestones.
0Weeks0Days0Hours0Minutes0Seconds
YU10 – BE PART OF OUR 10th ANNIVERSARY
On December 3, 2012, Thomas Schirrmann founded the YUMAB GmbH as a spin-off of the University of Braunschweig together with phage display pioneer Stefan Dübel and the scientists André Frenzel and Michael Hust. Their vision was to advance antibody-based drug discovery with services for biotech and pharma R&D based on a unique technology platform. Since then, YUMAB has become a global player in the market for therapeutic antibody discovery and engineering.
Team YUMAB will celebrate the 10th anniversary throughout 2022 by sharing stories of major achievements, business, people, locations, and science with you on this website and we invite you to participate in our activities:
How do you remember YUMAB’s early years? What is your relationship to the company or the people? What’s so typical “YUMAB” that would fit to no other company? What is your message to the team? Please feel free to share memories, anecdotes and pictures with us.
Anniversary Event
PROGRAMM YU10
10:00 – 10:15 | Begrüßung & Moderation
Dr. Linda Kirchner & Alexander Ehm, YUMAB GmbH
10:15 – 10:40 | 10 Jahre YUMAB GmbH – Ein Biotech-Unternehmen ist gereift
Dr. Thomas Schirrmann, CEO der YUMAB GmbH
10:45 –11:00 | CORAT – Eine Ausgründung im Kampf gegen COVID-19
Dr. Andreas Herrmann, CEO der CORAT Therapeutics GmbH
11:25 – 11:55 | Antikörperentwicklung mittels Phage-Display Technologie
Antikörperentwicklung mittels Phage-Display Technologie: Erfahren – Bodenständig – Gut
Prof. Dr. Stefan Dübel, Leiter der Abteilung Biotechnologie, Technische Universität Braunschweig Prof. Dr. Michael Hust, Professor Biotechnologie, Technische Universität Braunschweig
12:00 – 12:25 | Translationale Forschung des HZI am Science Campus Braunschweig-Süd
Prof. Dr. Dirk Heinz, Wissenschaftlicher Geschäftsführer des HZI
14:45 – 15:45 | PODIUMSDISKUSSION
Biotech-Standort Braunschweig – Forschungscluster, Innovation, Wachstumsmöglichkeiten
Moderation: Martin Brüning
Leiter Corporate Newsroom, TÜV Nord Group
Dr. Thomas Schirrmann, CEO der YUMAB GmbH
Prof. Dr. Dirk Heinz, Wissenschaftlicher Geschäftsführer, HZI
Gerold Leppa, Wirtschaftsdezernent und Geschäftsführer der Braunschweig Zukunft GmbH Falko Mohrs, Niedersächsischer Minister für Wissenschaft und Kultur
Stephen Struwe-Ramoth, Geschäftsführer der NBank Capital Beteiligungsgesellschaft mbH
15:50 – 16:00 | Zusammenfassung & Schlussworte
Dr. Thomas Schirrmann
Milestones
2012
Founding of YUMAB GmbH
-
- Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua.
Founding of a biotechnology company by experts and pioneers in recombinant antibody technologies of the University of Braunschweig in Germany.
# of employees: 1
-
2013
First booth participation at Biotechnica in Hannover and Bio Europe
-
- First booth participation at Biotechnica in Hannover and Bio Europe
The first time on a conference stage at major trade shows to grab attention which clearly influenced the path and strategy of the YUMAB business model.
# of employees: 2
2013
-
2016
IHK Technology Transfer Award
-
- IHK Technology Transfer Award
YUMAB received the IHK Technology Transfer Award for the transfer of antibody generation technologies to industry.
# of employees: 10
-
2017
Innovation Award Niedersachsen
-
- Innovation Award Niedersachsen
For the development of human antibodies, YUMAB and TU Braunschweig received the Innovation Network Lower Saxony Award (1st place).
# of employees: 14
2017
-
2017
Founding of YUMAB Inc. Atlanta Georgia
-
- Founding of YUMAB Inc. Atlanta Georgia
Founding of the US subsidiary to be able to serve the American market more intensively.
# of employees: 14
-
2018
Relocation to the campus of the Helmholtz Centre for Infection Research
-
- Relocation to the campus of the Helmholtz Centre for Infection Research
Open house day with many interesting participants from the press, politics and science.
# of employees: 20
2018
-
2020
Spin-Off CORAT Therapeutics GmbH
Fighting COVID-19 with recombinant fully human antibodies.
# of employees: 25
2022
New Logo & Corporate Design
Our new logo – 2022 and beyond!
# of employees: 30
2022
YUMAB IN NUMBERS
200
partners
15.000
antibodies
650
laboratories m²
8
babies
100
conferences
500
projects
100
libraries
32.752
coffees
3
dogs
20
team events
10
fundings
28
employees
uncountable
brainstorming beers
350
office m2
Behind the Scenes
Guest Book
In the past 10 years, many people have contributed to YUMAB’s success: management & team, collaborators, business partners and clients all enabled independent growth and development from start-up to global player.
As part of the YUMAB community we invite you to write an entry in our 10th anniversary guestbook. Please be aware that the entries will be open to the public and by submitting your entry you agree to publication.
We are looking forward to your contribution!
3 entries.
Dear YUMAB Team, Congratulations to your 10th Anniversary! It has been a pleasure working with you and seeing you grow. Cheers to many more years and looking forward to seeing you again in Basel!
It has always been a great pleasure to follow you the past 10 years. It will continue to be for hopefully the many next decades! In french I would say "Bonne continuation, chers amis!"
Dear all,
congrats to 10 exciting years building up a reliable company with a great and dedicated team, superior technology and last not but least sustainable growth.
Wish you all the best for the coming years,
Andreas
Survey for our Anniversary
YUMAB GmbH
Science Campus Braunschweig-Süd
Inhoffenstr. 7
38124 Braunschweig – Germany
Phone: +49 531 481170-0
Fax: +49-531 481170-17
